Nvidia has quietly become one of the most influential players in healthcare technology by supplying the accelerated computing and AI infrastructure that powers everything from imaging to drug discovery. The company’s restraint — focusing on enabling the ecosystem rather than owning it — has helped cement its role as the indispensable backbone of the healthcare industry’s AI transformation.
Philips showcased two major imaging innovations at RSNA 2025 — one a CT system that integrates AI into its hardware, and the other a new helium-free MRI model that embeds AI directly into signal acquisition. Both aim to improve image quality, efficiency and ease of integration — but commercial availability and real-world adoption are still forthcoming.
Alan Murray on improving access for medical transportation.
Philips is using its patient monitoring devices to help health systems deliver care more efficiently, especially in areas with specialist shortages. The company’s connected devices enable continuous monitoring from home to hospital and back, which can reduce diagnostic delays and improve patient safety, said Nick Wilson, Philps’ vice president of global marketing and product for ambulatory monitoring and diagnostics.
During Reuters’ MedTech conference, medical device leaders shared three common misconceptions they believe hospital leaders often have about AI. They stressed that AI in healthcare is meant to augment — not replace — clinicians.
Philips is showcasing its partnerships and new products at RSNA 2024, including an expanded collaboration with AWS and a CT scanner that the company said uses up to 80% less radiation than traditional systems.
A 10-year partnership between the two organization will standardize patient monitoring hardware and software across 49 Bon Secours Mercy Health hospitals.
CEO and neuroscientist Dr. Iftach Dolev on how the new device can bring a powerful tool to psychiatrists and neurologists alike.
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
At a recent conference, executives from across the industry shared their thoughts on how the healthcare sector can ensure its use of AI is ethical and responsible. They highlighted the need for collaboration, trust building and pragmatic thinking.
This year's HIMSS conference featured a variety of news announcements — from acquisitions to new product launches to advanced partnerships. In this list, MedCity News compiled short summaries for six of the conference's most notable announcements.
At HIMSS, Philips and AWS announced that they are expanding their collaboration with the goal of scaling digitized pathology slides in the cloud. The partners seek to help pathology labs better store and analyze vast volumes of data, as well as adopt more streamlined, cloud-based workflows to reduce clinician burnout.
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
Two of Philips' most notable RSNA announcements were that its new cloud-based PACS is available and that its helium-free mobile MRI system will soon be deployed. More than 80 sites across the U.S. and Latin America have already migrated to Philips' new PACS, and its mobile MRI system will be traveling to various cities next year.
The digital pathology market is poised for rapid growth in the U.S., with several vendors vying for dominance. The imaging management systems made by Leica Biosystems and Philips seem to be leading the pack in this competitive market, according to a new report.
The FDA granted 510(k) clearance to two of Philips’ newest acute care patients monitors, the IntelliVue MX750 and MX850. A year ago, the company had gotten an emergency use authorization for its monitors.
Paris-based Cardiologs has a software platform to screen for arrhythmias from ECG data. It would add to Philips' portfolio of cardiac software for hospitals and remote monitoring.
The reimbursement model for remote patient monitoring needs to evolve as it may be holding providers back from investing in these programs, according to panelists at the MedCity INVEST Digital Health conference. Key issues with the structure as it stands now include the fact that there are too many gray areas that result in claims denials.